Show results for
Refine by
Cancer Detection Suppliers Serving Malta
66 companies found
based inHuntsville, ALABAMA (USA)
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to ...
based in, GERMANY
Since 1971, the family company CLA – Coburger Lehrmittelanstalt, company owner: Hans Sommer, has been offering CLA Nursing Dolls, Medical Training Phantoms, and the entire programme of Original SOMSO Models, thus providing a wide range for the ...
Produced in co-operation with Prof. Dr. J. Sökeland, Dortmund. Made of special plastic. An urological practice model that allows rectal examinations and palpation of the testicles to be learned under true-to-life ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
PancreaDix is an innovative, non-invasive signature in blood for: Confirming a Pancreatic cancer diagnosis. Detecting pre-malignant lesions that will evolve to cancer. Performing a differential ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed ...
based inBerlin, GERMANY
3B Pharmaceuticals GmbH (3BP) is a German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. As a leader in peptide discovery and optimization, 3BP has built a ...
Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Targeted radiopharmaceuticals bind to specific structures such as proteins or cells within the body ...
based inLondon, UNITED KINGDOM
At Kheiron, we believe that by combining human intelligence with the power of AI, we can help transform cancer diagnostics. Detecting cancer and tracking it accurately is challenging and time-consuming for even the most experienced radiologists. ...
Mia® is our breakthrough AI platform for breast screening. A suite of solutions, Mia empowers radiologists and screening services to deliver confident, accurate and timely results to every woman, everywhere. Discover how Mia delivers ...
based inArnhem, NETHERLANDS
Soteria Medical B.V. is a Spin Off from Radboudumc in Nijmegen, The Netherlands. Many years of development and clinical research have resulted in a new approach to perform MRI guided interventions by utilizing a robotic device, which is fully ...
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening ...
based inWaterside, UNITED KINGDOM
Lightpoint Medical is a technology leader in targeted cancer surgery. We are developing miniaturized imaging and sensing tools for more precise intra-operative cancer detection. Our mission is to improve the lives of people with cancer by ...
Using next-generation miniaturized sensor technology, the SENSEI probe measures just over 40mm in length, enabling unprecedented intracavity maneuverability and anatomic access for surgical ...
based inCarlsbad, CALIFORNIA (USA)
We are a global medical technology company committed to providing peace of mind to patients and physicians alike through the use of MBI and PET as secondary screening and diagnostic tools. Both the LumaGEM ® Molecular Breast Imaging (MBI) system and ...
The LumaGEM® Molecular Breast Imaging system’s patented mounting mechanism allows the use of light breast immobilization for greater patient comfort during breast cancer imaging exam. The LumaGEM MBI system for breast cancer imaging ...
based inKaohsiung City, TAIWAN
EPED Inc. is a leading company in the field of minimally invasive surgery. Upholding the values of “safety, precision, and efficiency”, we strive constantly to develop innovative medical and dental navigation solutions. From education, training ...
EPROB Robotic Arm + AI is the newest member of the EPED Inc. family. Having been in production for nearly decade, a heavy emphasis on precision, safety, and minimally invasive surgeries are just some of the features that have been developed in that ...
based inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per ...
based inColorado Springs, COLORADO (USA)
World-class diagnostic imaging services are what Envision Radiology is all about. From the moment you contact us to when you step inside the facility of one of our centers, you can expect that your health and quality of life is our number one ...
A CAT Scan or computed tomography (CT), is a medical imaging method that produces a volume of data that can be manipulated (through a process known as windowing) to demonstrate various bodily structures based on their ability to block the x-ray ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Empower screens for genes associated with ...
based inDunedin,, NEW ZEALAND
Pacific Edge is a cancer diagnostics company. We specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Our ...
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the ...
based inSouth San Francisco, CALIFORNIA (USA)
At Twist Bioscience, we work in the service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, our customers are developing ways ...
NGS-based liquid biopsy is a rapidly evolving application that requires accurate and precise reference standards. The Twist Pan-cancer Reference Standard is a high-quality, standardized control for use in the research and ...
based inMiserey, FRANCE
Innovative Solutions for Cancer Diagnostics. OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. ...
based inParis Cedex 06, FRANCE
We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...
ISET, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
Trublood is an advanced non-invasive blood test (which provides diagnostically relevant information about cancers via a safe, simple and quick blood draw). Trublood® evaluates blood sample to detect ...